Cardiovascular
Cardiovascular Surgery
0
Pipeline Programs↗
4
Active Trials↗
4
Companies Involved↗
Cardiovascular Surgery is an early-stage landscape with 0 programs across 4 companies. The most active players are Nabi Biopharmaceuticals, Quark Pharmaceuticals, CSL Behring.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed8 · 57%
Recruiting2 · 14%
Unknown status2 · 14%
Enrolling by invitation1 · 7%
Not yet recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Clemastine in Cardiovascular Surgery
Completed·—·N/A·NCT03826004·100 enrolled
Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation
Completed·FFundación Canaria Rafael Clavijo para la Investigación Biomédica·Phase 4·NCT01078818·159 enrolled
Effectiveness of a Nursing Intervention for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery. Design and Evaluation of a Nursing Educational Program for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery.
Completed·—·Preclinical·NCT07680192·261 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)